Showing results (121-130 of 270) with videos related to

Sort By:
Pageof 27
Lung Cancer (Amsterdam, Netherlands)|August 17, 2021
Lung adenocarcinoma with ERBB2 exon 20 insertions: Comutations and immunogenomic features related to chemoimmunotherapyPanwen Tian, Hao Zeng, Liyan Ji, et al.
Nature Reviews. Clinical Oncology|November 11, 2025
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC - mechanisms and evolving treatment approachesJing Zhao, Wanting Xu, Fei Zhou, et al.
Cancer Treatment Reviews|February 12, 2022
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumoursStefania Crucitta, Federico Cucchiara, Ron Mathijssen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 26, 2021
Estrogen Promotes Resistance to Bevacizumab in Murine Models of NSCLCSonia A Patel, Matthew H Herynk, Tina Cascone, et al.
Anticancer Research|January 2, 2020
Efficacy of Anti-PD1/PD-L1 Therapy (IO) in KRAS Mutant Non-small Cell Lung Cancer Patients: A Retrospective AnalysisLetizia Gianoncelli, Gianluca Spitaleri, Antonio Passaro, et al.
International Journal of Molecular Sciences|August 17, 2019
Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment StrategyMarzia Del Re, Stefania Crucitta, Giulia Gianfilippo, et al.
Expert Review of Molecular Diagnostics|July 19, 2021
The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapiesIlaria Attili, Marzia Del Re, Elena Guerini-Rocco, et al.
Pageof 27